PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Methanol or water extracts of E. abyssinica were studied for their potential to reduce neuroinflammation and prevent meningoencephalitis [PMID:24452611]
Stem bark extract showed effects on body weight, triglycerides, sterol, total protein, and catalase activity in obese flies [PMID:35847607]
Chalcones abyssinones 1, 3, and 4 exhibited moderate cytotoxic activity with IC(50) values between 11.1 and 15.1 microM [PMID:18484536]
Ptercarpan derivatives showed strong cytotoxic activity and PTP1B inhibitory activity [PMID:19836230]
Evidence summary
PubMed sources
- 1.PMID: 33763144 (2021) — Traditional Medicinal Uses, Phytoconstituents, Bioactivities, and Toxicities of Erythrina abyssinica Lam. ex DC. (Fabaceae): A Systematic Review. · Evidence-based complementary and alternative medicine : eCAM
- 2.PMID: 9548845 (1998) — Minor Flavanones from Erythrina abyssinica. · Journal of natural products
- 3.PMID: 24452611 (2014) — Erythrina abyssinica prevents meningoencephalitis in chronic Trypanosoma brucei brucei mouse model. · Metabolic brain disease
- 4.PMID: 22978690 (2012) — The anti-obesity potential of sigmoidin A. · Pharmaceutical biology
- 5.PMID: 35847607 (2022) — Anti-obesity effects of Erythrina abyssinica stem bark extract in flies exposed to a high fat diet.